Annual Shareholders Equity
$13.41 M
-$48.77 M-78.43%
December 31, 2023
Summary
- As of February 8, 2025, VAXX annual stockholders equity is $13.41 million, with the most recent change of -$48.77 million (-78.43%) on December 31, 2023.
- During the last 3 years, VAXX annual shareholders equity has risen by +$100.78 million (+115.35%).
- VAXX annual shareholders equity is now -89.57% below its all-time high of $128.62 million, reached on December 31, 2021.
Performance
VAXX Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$13.41 M
-$10.30 M-43.43%
December 31, 2023
Summary
- As of February 8, 2025, VAXX quarterly stockholders equity is $13.41 million, with the most recent change of -$10.30 million (-43.43%) on December 31, 2023.
- Over the past year, VAXX quarterly shareholders equity has dropped by -$48.77 million (-78.43%).
- VAXX quarterly shareholders equity is now -89.57% below its all-time high of $128.62 million, reached on December 1, 2021.
Performance
VAXX Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
VAXX Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -78.4% | -78.4% |
| 3 y3 years | +115.3% | +115.3% |
| 5 y5 years | +127.6% | - |
VAXX Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -89.6% | at low | -89.6% | at low |
| 5 y | 5-year | -89.6% | +115.3% | -89.6% | +108.5% |
| alltime | all time | -89.6% | +115.3% | -89.6% | +108.5% |
Vaxxinity Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $13.41 M(-78.4%) | $13.41 M(-43.4%) |
| Sep 2023 | - | $23.70 M(-32.3%) |
| Jun 2023 | - | $35.01 M(-24.1%) |
| Mar 2023 | - | $46.13 M(-25.8%) |
| Dec 2022 | $62.18 M | $62.18 M(-22.5%) |
| Sep 2022 | - | $80.26 M(-17.5%) |
| Jun 2022 | - | $97.34 M(-13.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $112.66 M(-12.4%) |
| Dec 2021 | $128.62 M(-247.2%) | - |
| Dec 2021 | - | $128.62 M(-181.7%) |
| Sep 2021 | - | -$157.37 M(+11.0%) |
| Jun 2021 | - | -$141.82 M(+62.3%) |
| Dec 2020 | -$87.38 M(+80.1%) | - |
| Dec 2020 | - | -$87.38 M |
| Dec 2019 | -$48.51 M | - |
FAQ
- What is Vaxxinity annual stockholders equity?
- What is the all time high annual shareholders equity for Vaxxinity?
- What is Vaxxinity annual shareholders equity year-on-year change?
- What is Vaxxinity quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Vaxxinity?
- What is Vaxxinity quarterly shareholders equity year-on-year change?
What is Vaxxinity annual stockholders equity?
The current annual shareholders equity of VAXX is $13.41 M
What is the all time high annual shareholders equity for Vaxxinity?
Vaxxinity all-time high annual stockholders equity is $128.62 M
What is Vaxxinity annual shareholders equity year-on-year change?
Over the past year, VAXX annual stockholders equity has changed by -$48.77 M (-78.43%)
What is Vaxxinity quarterly stockholders equity?
The current quarterly shareholders equity of VAXX is $13.41 M
What is the all time high quarterly shareholders equity for Vaxxinity?
Vaxxinity all-time high quarterly stockholders equity is $128.62 M
What is Vaxxinity quarterly shareholders equity year-on-year change?
Over the past year, VAXX quarterly stockholders equity has changed by -$48.77 M (-78.43%)